Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population

Current Medical Research and Opinion

Volumn 24, Issue 9, 2008, Pages 2587-2595

  Wu, Eric ^a   Greenberg, Paul E ^a   Yang, Elaine ^a   Yu, Andrew ^a   Erder, M Haim ^b  

^a ANALYSIS GROUP   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

Author keywords

Citalopram; Escitalopram; Geriatric; Healthcare costs; Hospitalization; Major depressive disorder; Treatment compliance

Indexed keywords

CITALOPRAM; ESCITALOPRAM;

AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST CONTROL; DOSE RESPONSE; DRUG COST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL SERVICE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCRIPTION; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOSPITALIZATION; HUMANS; MALE; PATIENT COMPLIANCE; SEROTONIN UPTAKE INHIBITORS;

EID: 53349173864     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802303525     Document Type: Article

References (23)

1. Mental Health: A report from the Surgeon General. Available from http://www.surgeongeneral.gov/library/mentalhealth/home.html [Accessed 25/7/2007]
2. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-75
3. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-18
4. Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv 1999;50:1158-66
5. Glasser M, Gravdal JA. Assessment and treatment of geriatric depression in primary care settings. Arch Fam Med 1997;6:433-8
6. Bartels SJ, Horn S, Sharkey P, et al. Treatment of depression in older primary care patients in health maintenance organizations. Int J Psychiatry Med 1997;27:215-31
7. Feighner JP, Overo K. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 1999;60:824-30
8. Franchini L, Zanardi R, Gasperini M, et al. Two-year maintenance treatment with citalopram, 20mg, in unipolar subjects with high recurrence rate. J Clin Psychiatry 1999; 60:861-5
9. Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiatry 2004; 65:1190-6
10. Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331-6
11. Lepola UM, Loft H, Reines EH. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003; 18:211-7
12. Rapaport MH, Bose A, Zheng H. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry 2004;65:44-9
13. Wade A, Despiegel N, Heldbo Reines E. Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry 2006;18:83-9
14. Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005;20:131-7
15. Schmitt L, Tonnoir B, Arbus C. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder. Neuropsychobiology 2006;54:201-7
16. Fantino B, Moore N, Verdoux H, et al. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder. Int Clin Psychopharmacol 2007;22:107-15
17. Klysner R, Bent-Hansen J, Hansen HL, et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002;181:29-35
18. Kasckow JW, Welge J, Carroll BT, et al. Citalopram treatment of minor depression in elderly men: an open pilot study. Am J Geriatr Psychiatry 2002;10:344-7
19. Karlsson I, Godderis J, Auguste, De Mendonca Lima C, et al. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. Int J Geriatr Psychiatry 2000;15:295-305
20. Gorwood P, Weiller E, Lemming O, et al. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007;15:581-93
21. Kasper S, Lemming OM, De Swart H. Escitalopram in the longterm treatment of major depressive disorder in elderly patients. Neuropsychobiology 2006;54:152-9
22. Antidepressant medication management. The state of health care quality, National Committee for Quality Assurance, Washington, D.C. 2006;19
23. Unutzer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. JAMA 1997;277: 1618-23